Le Lézard

News by subject: TRI

1 2 3 4 5 6 7 8 9 10

Today

02:13
InDex Pharmaceuticals Holding AB (publ) today announced that SEK 2.0 million has been granted from Sweden's innovation agency Vinnova to develop new, more effective and safer treatments for inflammatory diseases. The grant from Vinnova within the...


30 march 2020

21:00
The Global Health Innovative Technology (GHIT) Fund announced today a total of 3.29 billion yen (US$30 million*) to invest in 11 partnerships to develop new lifesaving drugs, vaccines and diagnostics for malaria, tuberculosis, Chagas disease,...

16:12
IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") announces that its collaborator, EVQLV, has submitted their first panel of candidate therapeutic antibody sequences,...

15:30
Mount Sinai researchers have discovered a pathway that regulates special immune system cells in lung cancer tumors, suppressing them and allowing tumors to grow. The scientists also figured out how to interrupt this pathway and ramp up the immune...

12:15
Expert System, an Artificial Intelligence global company headquartered in Modena, Italy, joins the fight against COVID-19 by granting biomedical researchers worldwide free access to its AI-based Clinical Research Navigator (CRN) tool effective...

11:46
Results from separate positive Phase 3 trial of Praluent® (alirocumab) in patients with HoFH also presented; FDA regulatory submission planned for Q2 2020 Regeneron Pharmaceuticals, Inc. announced that detailed Phase 3 results of evinacumab were...

11:02
Houston Methodist received FDA approval Saturday to become the first academic medical center in the nation to transfuse donated plasma from a recovered COVID-19 patient into a critically ill patient. This treatment was fast-tracked to the bedside...

11:00
An artificial intelligence tool accurately predicted which patients newly infected with the COVID-19 virus would go on to develop severe respiratory disease, a new study found. ...

09:05
Kate Farms, the #1 recommended plant-based formula prescribed to deliver vital medical nutrition to people with chronic diseases today announced the publication of new clinical data that demonstrates improved GI tolerance in a variety of populations...

09:00
'hzVSF v13 (humanized Virus Suppressing Factor; VSF)', a treatment that can be used for a wide range of viral diseases developed by ImmuneMed, was administered on March 28th at Yonsei University Hospital to treat COVID-19 pneumonia patients. It was...

09:00
Amidst the chaos created by the corona virus pandemic, health care systems worldwide are in desperate need of effective and improved telehealth platforms. Now more than ever, remote diagnostics and digital treatments are not only relevant but...

09:00
INOVIO Pharmaceuticals, Inc. today reported interim results from an open-label Phase 2 trial designed to evaluate the safety and efficacy of VGX-3100 in women with vulvar dysplasia, also known as high grade squamous intraepithelial lesion (HSIL), a...

08:05
Harmony Biosciences, LLC ("Harmony"), a private pharmaceutical company dedicated to developing and commercializing novel treatment options for people living with rare diseases, announced today that Sleep Medicine has published an article which...

08:00
Cardax, Inc. reported its 2019 results. Highlights: CHASE Clinical Trial. On September 23, 2019, the Company announced findings from the pre-specified interim review of its ongoing CHASE (Cardiovascular Health Astaxanthin Supplement Evaluation)...

08:00
Nano Retina Ltd., developer of the NR600, an artificial retina device that mimics the natural physiological processes of the human eye and restores functional vision to persons blinded by retinal degenerative diseases, including age-related macular...

08:00
ERT, a global data and technology company that captures critical endpoint data while minimizing uncertainty and risk in clinical trials, today announced a cardiac safety solution that helps biopharmaceutical researchers continue important clinical...

07:58
Immunovia invites you to a teleconference (in English) for all stakeholders and media on Wednesday, April 1, 2020 at 16:30 CET. Mats Grahn, CEO will present an update on the company's COVID-19 response as well as an update on the activities in...

07:30
Biohaven Pharmaceutical Holding Company Ltd. today announced positive topline results in its randomized, placebo-controlled pivotal clinical trial (NCT03732638) evaluating the efficacy and safety of oral rimegepant 75 mg for the preventive treatment...

07:22
Johnson & Johnson ...

07:00
Bio-Techne Corporation today announced researchers from its Munich-based laboratory, Exosome Diagnostics, in a paper published in the scientific Journal of Extracellular Vesicles (JEV) (link), showed that tumor- derived RNA was not detected in...

06:45
Eli Lilly and Company announced today the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) for Taltz® (ixekizumab) injection, 80 mg/mL for the treatment of pediatric patients (ages 6 to under...

06:01
Around 20 surgeons and 20 nurses from leading European hospitals, across urology, gynaecology and general surgery participated in Dexter validation end of February and early March 2020 Surgical teams successfully performed surgical procedures using...

06:00
Synlogic, Inc. , a clinical stage company applying synthetic biology to beneficial microbes to develop novel, living medicines called Synthetic Biotictm medicines, today provided an update on its business operations and expected clinical...

05:00
Vaccitech Ltd, a clinical stage biopharmaceutical company developing immunotherapies to treat infectious diseases and cancer, announced today that its Chief Executive Officer, Bill Enright, will present an update on the Company's progress at the...

03:00
Nano Retina Ltd., developer of the NR600, an artificial retina device that mimics the natural physiological processes of the human eye and restores functional vision to persons blinded by retinal degenerative diseases, including age-related...

02:27
Isofol Medical AB (publ), , today announced that new gene expression data based on a validated method from TATAA Biocenter AB, which is significantly more sensitive than the pre-commercial method, shows that a larger proportion of patients, i.e....

00:59
Phase 2/3 trial initiated in Italy, Spain, Germany, France, Japan, Canada and Russia and is enrolling patients immediately Kevzara inhibits IL-6, which may play a role in driving the inflammatory immune response that causes acute respiratory distress...


28 march 2020

11:01
Novartis today announced results from a prespecified analysis of pooled data from three Phase III studies evaluating the safety and efficacy of inclisiran, its first-in-class investigational treatment for hyperlipidemia in adults. The data was...

10:13
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the VOYAGER PAD study met its primary efficacy and principal safety endpoints, demonstrating the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily) plus aspirin (100 mg...

10:00
Amgen today announced positive results from the EvolocumaB Effect on LDL-C LowerIng in SubJEcts with Human Immunodeficiency ViRus and INcreased Cardiovascular RisK (BEIJERINCK) study evaluating the efficacy and safety of Repatha® (evolocumab) in...

10:00
Edwards Lifesciences Corporation , the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced it will temporarily pause new enrollments in its active pivotal clinical trials of...

10:00
Ryvu Therapeutics (WSE: RVU), a clinical-stage biopharmaceutical company developing novel small molecule therapies that address emerging targets in oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted an orphan drug...


27 march 2020

18:09
HealthTree®, the first online portal for multiple myeloma cancer patients to find their best treatment options and help accelerate a cure, today announced plans for an observational study to look at the impact of the novel coronavirus (COVID-19) on...

12:11
Pharming announces the Committee for Medicinal Products for Human Use (CHMP), an advisory committee of the European Medicine Agency (EMA), has adopted a positive opinion recommending an extension of the indication for RUCONEST® to the European...

11:29
The National Kidney Foundation (NKF) showcased three late-breaking studies to kidney professionals this week during their annual Spring Clinical Meetings, which were held this year as a live-virtual gathering due to the COVID-19 crisis....

09:00
Guangzhou XlifeSciences, a partner of GenScript ProBio (GenScript's CDMO segment) announced that the early phase clinical trial of TAEST16001 project has been started. GenScript ProBio extends congratulations on this. This clinical trial project is...

07:00
Alphamab Oncology (stock code: 9966HK) announced today that Jiangsu Alphamab Biopharmaceuticals Co., Ltd. ("Jiangsu Alphamab"), a wholly-owned subsidiary of the Company, has entered a clinical supply agreement with Pfizer Inc. ("Pfizer") to advance a...


26 march 2020

18:00
Today, DotLab -- a molecular diagnostics company on the front lines of research and development in women's health -- announced the publication of a study validating  its non-invasive test for endometriosis. The study appears in the American Journal...

16:42
Evolve BioSystems, Inc., a global leader dedicated to improving human health through the gut microbiome, today announced a collaboration with Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to...

16:32
Today, Innoplexus AG announced some first results in its artificial intelligence enabled search for a COVID-19 antiviral treatment.  Innoplexus began by scanning data on previously approved drugs for off-label potential in treating COVID-19, using...

16:00
Hemodialysis patients treated with Optiflux® high flux single-use dialyzers experienced a mean increase in serum albumin levels, according to results from a recent clinical trial and separate retrospective analysis conducted by Fresenius Medical Care...

13:04
Advarra announces the availability of free resources to support and enable the clinical research community and ongoing research during the coronavirus disease (COVID-19) crisis. This includes complimentary transfer of IRB oversight, access to a new...

11:32
Bosch Healthcare Solutions is currently working on the development of a COVID-19 rapid testing kit for the Vivalytic platform and will launch this in April 2020. The Vivalytic VRI test (Viral Respiratory Tract Infections) checks the patient's sample...

09:45
Microbiologists have long adopted the language of human settlement to describe how bacteria live and grow. A new study in Nature Communications uses super-resolution imaging and a computational algorithm to confirm the aptness of this metaphor: As...

09:06
Citius Pharmaceuticals, Inc. ("Citius" or the "Company") , a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced today the publication of an in vitro study for Mino-Lok®, the Company's...

09:00
Bio-Pharm Solutions Co., Ltd. has expanded its clinical pipelines from infantile spasms (IS) to status epilepticus (SE) and Alzheimer's disease. Based on the performance of its first pipeline, an infantile spasms drug, BIo-Pharm Solutions is...

09:00
INOVIO Pharmaceuticals, Inc. today announced positive interim results from an open-label, Phase 2 study showing its lead DNA medicine candidate VGX-3100 to be safe and effective in treating men and women with anal dysplasia, also known as high grade...

08:18
Medimetriks Pharmaceuticals, Inc. today announced that its partner, Otsuka Pharmaceuticals Co. Ltd., achieved positive results in two Phase 3 Japanese clinical trials in adult and pediatric patients for MM36 (difamilast), a novel topical,...

08:00
Tolero Pharmaceuticals, Inc., a clinical-stage company focused on developing novel therapeutics for hematological and oncological diseases, today announced that it has joined The Leukemia & Lymphoma Society (LLS) in the groundbreaking, collaborative...

08:00
Bolt Biotherapeutics, Inc., a private biotechnology company developing its Immune-Stimulating Antibody Conjugate (ISAC) platform technology to harness the power of the immune system to treat cancer, today announced that patient dosing has begun in...

1 2 3 4 5 6 7 8 9 10